Accelerate Biomarker Discovery In small, early-phase cohorts

(as few as ~20 responders per indication)

To mark one year since our invitation-only program with select partners, we are launching the OI Suite Discovery Program

OI Suite is a SaaS enterprise platform designed to address one of oncology’s most pressing challenges: discovering biomarkers and identifying the right patients from limited, heterogeneous data, enabling biopharma to accelerate precision drug development, increase predictive power, and support evidence-based trial design and cohort enrichment.

The OI Suite Key Advantages

Multimodal Intelligence for Deeper Insights

OI Suite integrates histopathology, genomics, and clinical data through Imagene’s Cross-Modality Intelligence Engine to derive biologically grounded insights. It enhances biomarker discovery, supports patient stratification, and enables more informed decisions across translational and clinical research.

High Predictive Power in Low-Data Settings

Powered by foundation models including CanvOI (co-developed with Oracle and trained on 1.5 million slides), OI Suite delivers high predictive power in small clinical cohorts. It enables no-code modeling, cohort enrichment, and early feasibility assessment leveraging multimodal AI and Real-World Data.

Accessible, Evidence-Driven Research Platform

OI Suite translates complex multimodal AI into practical, intuitive tools that require no coding or AI expertise. Interactive heatmaps and cell-level visualizations trace predictions back to morphology, and biomarker insights allow researchers to generate and test hypotheses quickly and accelerate discovery.

OI Suite Discovery - Selected Use Cases

Biomarker Detection Model - Identifying EGFR Mutations from H&E

Independently develop a Biomarker Detection model (an AI pre-screening tool) within minutes using public real-world data
Gleason Score Detection from H&E

Train and visualize a Gleason Score grading model with heatmaps highlighting predicted tumor grades, using public real-world data
Smoking Status Biomarker Discovery Using Public Real-World Data

Train a predictor and identify top contributing features driving model predictions.

See

in action

Imagene AI will showcase OI Suite Discovery on a webinar. Details to come soon

Talk to us about the Full OI Suite

Expand to gene expression, mutational profiles, and clinical records leveraging the OI Suite Cross-Modality Intelligence Engine. Upload your own proprietary data and more…

OI Suite Discovery

is Powered by

Our state-of-the-art Oncology Intelligence foundation model co-developed with Oracle and trained on more than 1.5 million tissue samples across 40+ organs and tissue types.

When benchmarked against publicly available foundation models, CanvOI achieved up to 20% higher performance in low-data settings.

All research is conducted on de-identified data under rigorous privacy, security, and institutional oversight.